SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-04-153620
Filing Date
2004-09-08
Accepted
2004-09-08 17:07:17
Documents
3
Period of Report
2004-09-08
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 13522
2 PRESS RELEASE dex991.htm EX-99.1 10799
3 GRAPHIC g20853im44.jpg GRAPHIC 25028
  Complete submission text file 0001193125-04-153620.txt   51311
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15070 | Film No.: 041021201
SIC: 2834 Pharmaceutical Preparations